NUVARING
0,12MG/0,015MG/24H VAG INS 3
| SÚKL code | 0120188 |
|---|---|
| Name of the product | NUVARING |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | NUVARING |
| Supplement | 0,12MG/0,015MG/24H VAG INS 3 |
| Strenght | 0,12MG/0,015MG/24H |
| Pharmaceutical form | Vaginal delivery system |
| Package | 3 |
| Route | Vaginal use |
| Language of the pack | Czech |
| Wrap type | Sachet |
| Legal status | na lékařský předpis |
| Active substance |
ETHINYLESTRADIOL (ETHINYLESTRADIOLUM) ETONOGESTREL (ETONOGESTRELUM) |
| ATC group | G02BB01 |
| ATC group name | VAGINÁLNÍ KROUŽEK S PROGESTINEM A ESTROGENEM |
Marketing authorisation information
| Registration Number | 17/ 408/07-C |
|---|---|
| Type of MA | A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state |
| MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
| Placed on the market till | 31. 12. 2018 |
| MA Holder | N.V. Organon, Oss |
| MA Holder country | NIZOZEMSKO |
| Actual MA holder | Merck Sharp & Dohme B.V., Haarlem |
| Actual MA holder country | NIZOZEMSKO |
cz